Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study.
Satoi S, Yamamoto T, Uchida K, Fujii T, Kin T, Hirano S, Hanada K, Itoi T, Murakami Y, Igarashi H, Eguchi H, Kuroki T, Shimizu Y, Tani M, Tanno S, Tsuji Y, Hirooka Y, Masamune A, Shimokawa T, Yamaue H, Okazaki K; Committee of Clinical Research, Japan Pancreas Society.
Satoi S, et al. Among authors: shimokawa t.
Pancreas. 2020 Jul;49(6):837-844. doi: 10.1097/MPA.0000000000001579.
Pancreas. 2020.
PMID: 32590619